Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.1.1. Treatment
1.1.2. End Use
1.1.3. Regional scope
1.1.4. Estimates and forecast timeline
1.2. Market Definitions
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. Internal Database
1.5. Details of primary research
1.5.1. Data for primary interviews in North America
1.5.2. Data for primary interviews in Europe
1.5.3. Data for primary interviews in Asia Pacific
1.5.4. Data for primary interviews in Latin America
1.5.5. Data for Primary interviews in MEA
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.1.1. Approach 1: Commodity flow approach
1.7.2. Volume price analysis (Model 2)
1.7.2.1. Approach 2: Volume price analysis
1.8. Research Scope and Assumptions
1.8.1. List of Secondary Sources
1.8.2. List of Primary Sources
1.8.3. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Hemorrhagic & Ischemic Stroke Treatment Devices Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Drivers Analysis
3.2.1.1. Rising burden of hemorrhagic stroke
3.2.1.2. Growing focus on minimally invasive procedures
3.2.1.3. Technological advancements in neurovascular devices
3.2.2. Market Restraints Analysis
3.2.2.1. High cost of devices and procedures
3.2.2.2. Product recalls
3.2.3. Market Opportunity Analysis
3.2.3.1. Growing emphasis on R&D expansion
3.2.3.2. Rising public awareness about hemorrhagic stroke
3.2.3.3. Increasing clinical trials
3.2.3.4. Increasing launches of devices for ischemic stroke treatment
3.2.3.5. Expansion opportunities in emerging markets
3.2.3.6. Rising stroke incidence among younger adults
3.2.4. Market Challenge Analysis
3.2.4.1. Complications associated with neurovascular treatments
3.2.4.2. Limited skilled professionals
3.3. Hemorrhagic & Ischemic Stroke Treatment Devices Market Analysis Tools
3.3.1. Porter’s Analysis
3.3.1.1. Bargaining power of the suppliers
3.3.1.2. Bargaining power of the buyers
3.3.1.3. Threats of substitution
3.3.1.4. Threats from new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic and Social landscape
3.3.2.3. Technological landscape
3.3.2.4. Environmental landscape
3.3.2.5. Legal landscape
Chapter 4. Hemorrhagic & Ischemic Stroke Treatment Devices Market: Treatment Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Global Hemorrhagic & Ischemic Stroke Treatment Devices Market: Treatment Movement Analysis, 2025 & 2033 (USD Million)
4.3. Global Hemorrhagic & Ischemic Stroke Treatment Devices Market Size & Trend Analysis, by Treatment, 2021 to 2033 (USD Million)
4.4. Aneurysm & Hemorrhagic Stroke Interventions
4.4.1. Aneurysm & hemorrhagic stroke interventions market revenue estimates and forecasts, 2021-2033 (USD Million)
4.4.2. By indication
4.4.2.1. By indication market revenue estimates and forecasts, 2021-2033 (USD Million)
4.4.2.2. Intracranial aneurysm
4.4.2.2.1. Intracranial aneurysm market revenue estimates and forecasts, 2021-2033 (USD Million)
4.4.2.3. cSDH (MMA Embolization)
4.4.2.3.1. cSDH (MMA Embolization) market revenue estimates and forecasts, 2021-2033 (USD Million)
4.4.2.4. AVM & AVF embolization
4.4.2.4.1. AVM & AVF embolization market revenue estimates and forecasts, 2021-2033 (USD Million)
4.4.3. By device
4.4.3.1. By device market revenue estimates and forecasts, 2021-2033 (USD Million)
4.4.3.2. Embolization coiling systems
4.4.3.1.1. Embolization coiling systems market revenue estimates and forecasts, 2021-2033 (USD Million)
4.4.3.2. Flow diversion systems
4.4.3.2.1. Flow diversion systems market revenue estimates and forecasts, 2021-2033 (USD Million)
4.4.3.3. Intrasaccular flow disruption devices
4.4.2.3.1. Intrasaccular flow disruption devices market revenue estimates and forecasts, 2021-2033 (USD Million)
4.4.3.4. Liquid embolization agents
4.4.3.4.1. Liquid embolization agents market revenue estimates and forecasts, 2021-2033 (USD Million)
4.5. Ischemic Stroke Interventions (Mechanical Revascularization)
4.5.1. Ischemic stroke interventions (Mechanical Revascularization) market revenue estimates and forecasts, 2021-2033 (USD Million)
4.5.2. Stent retriever systems
4.5.2.1. Stent retriever systems market revenue estimates and forecasts, 2021-2033 (USD Million)
4.5.3. Aspiration-based thrombectomy systems
4.5.3.1. Aspiration-based thrombectomy systems market revenue estimates and forecasts, 2021-2033 (USD Million)
4.6. Cerebral Angioplasty & Vascular Remodeling
4.6.1. Cerebral angioplasty & vascular remodeling market revenue estimates and forecasts, 2021-2033 (USD Million)
4.6.2. Balloon angioplasty systems
4.6.2.1. Balloon angioplasty systems market revenue estimates and forecasts, 2021-2033 (USD Million)
4.6.3. Intracranial & carotid stenting systems
4.6.3.1. Intracranial & carotid stenting systems market revenue estimates and forecasts, 2021-2033 (USD Million)
4.6.4. Coil-assisted adjunctive devices (Balloon-assisted and stent-assisted)
4.6.4.1. Coil-assisted adjunctive devices (Balloon-assisted and stent-assisted) market revenue estimates and forecasts, 2021-2033 (USD Million)
4.7. Ancillary & procedural access devices
4.7.1. Ancillary & procedural access devices market revenue estimates and forecasts, 2021-2033 (USD Million)
4.7.2. Guiding & distal access catheters
4.7.2.1. Guiding & distal access catheters market revenue estimates and forecasts, 2021-2033 (USD Million)
4.7.3. Microcatheters
4.7.3.1. Microcatheters market revenue estimates and forecasts, 2021-2033 (USD Million)
4.7.4. Access sheaths & wires
4.7.4.1. Access sheaths & wires market revenue estimates and forecasts, 2021-2033 (USD Million)
Chapter 5. Hemorrhagic & Ischemic Stroke Treatment Devices Market: End Use Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Global Hemorrhagic & Ischemic Stroke Treatment Devices Market: End use Movement Analysis, 2025 & 2033 (USD Million)
5.3. Global Hemorrhagic & Ischemic Stroke Treatment Devices Market Size & Trend Analysis, by End use 2021 to 2033 (USD Million)
5.4. Hospitals
5.4.1. Hospitals market revenue estimates and forecasts, 2021-2033 (USD Million)
5.5. Specialty Neurosurgery Centers
5.5.1. Specialty neurosurgery centers market revenue estimates and forecasts, 2021-2033 (USD Million)
5.6. Ambulatory Surgical Centers
5.6.1. Ambulatory surgical centers market revenue estimates and forecasts, 2021-2033 (USD Million)
Chapter 6. Hemorrhagic & Ischemic Stroke Treatment Devices Market: Regional Estimates & Trend Analysis by Treatment, and End Use
6.1. Regional Dashboard
6.2. Market Size and Trend Analysis, 2021 to 2033
6.3. North America
6.3.1. North America hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021-2033 (USD Million)
6.3.2. U.S.
6.3.2.1. Key country dynamics
6.3.2.2. Competitive scenario
6.3.2.3. Regulatory framework
6.3.2.4. Reimbursement scenario
6.3.2.5. U.S. hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021-2033 (USD Million)
6.3.3. Canada
6.3.3.1. Key country dynamics
6.3.3.2. Competitive scenario
6.3.3.3. Regulatory framework
6.3.3.4. Reimbursement scenario
6.3.3.5. Canada hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021-2033 (USD Million)
6.3.4. Mexico
6.3.4.1. Key country dynamics
6.3.4.2. Competitive scenario
6.3.4.3. Regulatory framework
6.3.4.4. Reimbursement scenario
6.3.4.5. Mexico hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021-2033 (USD Million)
6.4. Europe
6.4.1. Europe hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021-2033 (USD Million)
6.4.2. UK
6.4.2.1. Key country dynamics
6.4.2.2. Competitive scenario
6.4.2.3. Regulatory framework
6.4.2.4. Reimbursement scenario
6.4.2.5. UK hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021-2033 (USD Million)
6.4.3. Germany
6.4.3.1. Key country dynamics
6.4.3.2. Competitive scenario
6.4.3.3. Regulatory framework
6.4.3.4. Reimbursement scenario
6.4.3.5. Germany hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021-2033 (USD Million)
6.4.4. France
6.4.4.1. Key country dynamics
6.4.4.2. Competitive scenario
6.4.4.3. Regulatory framework
6.4.4.4. Reimbursement scenario
6.4.4.5. France hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021-2033 (USD Million)
6.4.5. Italy
6.4.5.1. Key country dynamics
6.4.5.2. Competitive scenario
6.4.5.3. Regulatory framework
6.4.5.4. Reimbursement scenario
6.4.5.5. Italy hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021-2033 (USD Million)
6.4.6. Spain
6.4.6.1. Key country dynamics
6.4.6.2. Competitive scenario
6.4.6.3. Regulatory framework
6.4.6.4. Reimbursement scenario
6.4.6.5. Spain hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021-2033 (USD Million)
6.4.7. Sweden
6.4.7.1. Key country dynamics
6.4.7.2. Competitive scenario
6.4.7.3. Regulatory framework
6.4.7.4. Reimbursement scenario
6.4.7.5. Sweden hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021-2033 (USD Million)
6.4.8. Denmark
6.4.8.1. Key country dynamics
6.4.8.2. Competitive scenario
6.4.8.3. Regulatory framework
6.4.8.4. Reimbursement scenario
6.4.8.5. Denmark hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021-2033 (USD Million)
6.4.9. Norway
6.4.9.1. Key country dynamics
6.4.9.2. Competitive scenario
6.4.9.3. Regulatory framework
6.4.9.4. Reimbursement scenario
6.4.9.5. Norway hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021-2033 (USD Million)
6.5. Asia Pacific
6.5.1. Asia Pacific hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021-2033 (USD Million)
6.5.2. China
6.5.2.1. Key country dynamics
6.5.2.2. Competitive scenario
6.5.2.3. Regulatory framework
6.5.2.4. Reimbursement scenario
6.5.2.5. China hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021-2033 (USD Million)
6.5.3. Japan
6.5.3.1. Key country dynamics
6.5.3.2. Competitive scenario
6.5.3.3. Regulatory framework
6.5.3.4. Reimbursement scenario
6.5.3.5. Japan hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021-2033 (USD Million)
6.5.4. India
6.5.4.1. Key country dynamics
6.5.4.2. Competitive scenario
6.5.4.3. Regulatory framework
6.5.4.4. Reimbursement scenario
6.5.4.5. India hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021-2033 (USD Million)
6.5.5. South Korea
6.5.5.1. Key country dynamics
6.5.5.2. Competitive scenario
6.5.5.3. Regulatory framework
6.5.5.4. Reimbursement scenario
6.5.5.5. South Korea hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021-2033 (USD Million)
6.5.6. Australia
6.5.6.1. Key country dynamics
6.5.6.2. Competitive scenario
6.5.6.3. Regulatory framework
6.5.6.4. Reimbursement scenario
6.5.6.5. Australia hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021-2033 (USD Million)
6.5.7. Thailand
6.5.7.1. Key country dynamics
6.5.7.2. Competitive scenario
6.5.7.3. Regulatory framework
6.5.7.4. Reimbursement scenario
6.5.7.5. Thailand hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021-2033 (USD Million)
6.6. Latin America
6.6.1. Latin America hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021-2033 (USD Million)
6.6.2. Brazil
6.6.2.1. Key country dynamics
6.6.2.2. Competitive scenario
6.6.2.3. Regulatory framework
6.6.2.4. Reimbursement scenario
6.6.2.5. Brazil hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021-2033 (USD Million)
6.6.3. Argentina
6.6.3.1. Key country dynamics
6.6.3.2. Competitive scenario
6.6.3.3. Regulatory framework
6.6.3.4. Reimbursement scenario
6.6.3.5. Argentina hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021-2033 (USD Million)
6.7. Middle East and Africa
6.7.1. Middle East and Africa hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021-2033 (USD Million)
6.7.2. South Africa
6.7.2.1. Key country dynamics
6.7.2.2. Competitive scenario
6.7.2.3. Regulatory framework
6.7.2.4. Reimbursement scenario
6.7.2.5. South Africa hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021-2033 (USD Million)
6.7.3. Saudi Arabia
6.7.3.1. Key country dynamics
6.7.3.2. Competitive scenario
6.7.3.3. Regulatory framework
6.7.3.4. Reimbursement scenario
6.7.3.5. Saudi Arabia hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021-2033 (USD Million)
6.7.4. UAE
6.7.4.1. Key country dynamics
6.7.4.2. Competitive scenario
6.7.4.3. Regulatory framework
6.7.4.4. Reimbursement scenario
6.7.4.5. UAE hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021-2033 (USD Million)
6.7.5. Kuwait
6.7.5.1. Key country dynamics
6.7.5.2. Competitive scenario
6.7.5.3. Regulatory framework
6.7.5.4. Reimbursement scenario
6.7.5.5. Kuwait hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021-2033 (USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis by Key Market Participants
7.2. Company Categorization
7.3. Company Market Share Analysis, 2025
7.4. Company Heat Map Analysis
7.5. Strategy Mapping
7.5.1. Expansion
7.5.2. Mergers & Acquisition
7.5.3. Partnerships & Collaborations
7.5.4. New Treatment Launches
7.5.5. Research And Development
7.5.6. Company Profiles
7.5.7. Medtronic
7.5.7.1. Company overview
7.5.7.2. Financial performance
7.5.7.3. Treatment Benchmarking
7.5.7.4. Strategic initiatives
7.5.8. MicroVention, Inc. (Terumo Corporation)
7.5.8.1. Company overview
7.5.8.2. Financial performance
7.5.8.3. Treatment Benchmarking
7.5.8.4. Strategic initiatives
7.5.9. Balt
7.5.9.1. Company overview
7.5.9.2. Financial performance
7.5.9.3. Treatment Benchmarking
7.5.9.4. Strategic initiatives
7.5.10. Scientia Vascular, Inc.
7.5.10.1. Company overview
7.5.10.2. Financial performance
7.5.10.3. Treatment Benchmarking
7.5.10.4. Strategic initiatives
7.5.11. MicroPort Scientific Corporation
7.5.11.1. Company overview
7.5.11.2. Financial performance
7.5.11.3. Treatment Benchmarking
7.5.11.4. Strategic initiatives
7.5.12. Johnson & Johnson (MedTech)
7.5.12.1. Company overview
7.5.12.2. Financial performance
7.5.12.3. Treatment Benchmarking
7.5.12.4. Strategic initiatives
7.5.13. phenox GmbH (Wallaby Medical)
7.5.13.1. Company overview
7.5.13.2. Financial performance
7.5.13.3. Treatment Benchmarking
7.5.13.4. Strategic initiatives
7.5.14. Acandis GmbH
7.5.14.1. Company overview
7.5.14.2. Financial performance
7.5.14.3. Treatment Benchmarking
7.5.14.4. Strategic initiatives
7.5.15. B. Braun SE
7.5.15.1. Company overview
7.5.15.2. Financial performance
7.5.15.3. Treatment Benchmarking
7.5.15.4. Strategic initiatives
7.5.16. Integra LifeSciences
7.5.16.1. Company overview
7.5.16.2. Financial performance
7.5.16.3. Treatment Benchmarking
7.5.16.4. Strategic initiatives
7.5.17. Infinity Neuro LLC
7.5.17.1. Company overview
7.5.17.2. Financial performance
7.5.17.3. Treatment Benchmarking
7.5.17.4. Strategic initiatives
7.5.18. Penumbra, Inc.
7.5.18.1. Company overview
7.5.18.2. Financial performance
7.5.18.3. Treatment Benchmarking
7.5.18.4. Strategic initiatives
7.5.19. Boston Scientific Corporation
7.5.19.1. Company overview
7.5.19.2. Financial performance
7.5.19.3. Treatment Benchmarking
7.5.19.4. Strategic initiatives
7.5.20. Stryker
7.5.20.1. Company overview
7.5.20.2. Financial performance
7.5.20.3. Treatment Benchmarking
7.5.20.4. Strategic initiatives
7.5.21. Peter LAZIC GmbH
7.5.21.1. Company overview
7.5.21.2. Financial performance
7.5.21.3. Treatment Benchmarking
7.5.21.4. Strategic initiatives
7.5.22. Vesalio Inc.
7.5.22.1. Company overview
7.5.22.2. Financial performance
7.5.22.3. Treatment Benchmarking
7.5.22.4. Strategic initiatives
List of Tables
Table 1 List of abbreviation
Table 2 North America hemorrhagic & ischemic stroke treatment devices market, by region, 2021-2033 (USD Million)
Table 3 North America hemorrhagic & ischemic stroke treatment devices market, by treatment, 2021-2033 (USD Million)
Table 4 North America hemorrhagic & ischemic stroke treatment devices market, by end use, 2021-2033 (USD Million)
Table 5 U.S. hemorrhagic & ischemic stroke treatment devices market, by treatment, 2021-2033 (USD Million)
Table 6 U.S. hemorrhagic & ischemic stroke treatment devices market, by end use, 2021-2033 (USD Million)
Table 7 Canada hemorrhagic & ischemic stroke treatment devices market, by treatment, 2021-2033 (USD Million)
Table 8 Canada hemorrhagic & ischemic stroke treatment devices market, by end use, 2021-2033 (USD Million)
Table 9 Mexico hemorrhagic & ischemic stroke treatment devices market, by treatment, 2021-2033 (USD Million)
Table 10 Mexico hemorrhagic & ischemic stroke treatment devices market, by end use, 2021-2033 (USD Million)
Table 11 Europe hemorrhagic & ischemic stroke treatment devices market, by region, 2021-2033 (USD Million)
Table 12 Europe hemorrhagic & ischemic stroke treatment devices market, by treatment, 2021-2033 (USD Million)
Table 13 Europe hemorrhagic & ischemic stroke treatment devices market, by end use, 2021-2033 (USD Million)
Table 14 Germany hemorrhagic & ischemic stroke treatment devices market, by treatment, 2021-2033 (USD Million)
Table 15 Germany hemorrhagic & ischemic stroke treatment devices market, by end use, 2021-2033 (USD Million)
Table 16 UK hemorrhagic & ischemic stroke treatment devices market, by treatment, 2021-2033 (USD Million)
Table 17 UK hemorrhagic & ischemic stroke treatment devices market, by end use, 2021-2033 (USD Million)
Table 18 France hemorrhagic & ischemic stroke treatment devices market, by treatment, 2021-2033 (USD Million)
Table 19 France hemorrhagic & ischemic stroke treatment devices market, by end use, 2021-2033 (USD Million)
Table 20 Italy hemorrhagic & ischemic stroke treatment devices market, by treatment, 2021-2033 (USD Million)
Table 21 Italy hemorrhagic & ischemic stroke treatment devices market, by end use, 2021-2033 (USD Million)
Table 22 Spain hemorrhagic & ischemic stroke treatment devices market, by treatment, 2021-2033 (USD Million)
Table 23 Spain hemorrhagic & ischemic stroke treatment devices market, by end use, 2021-2033 (USD Million)
Table 24 Denmark hemorrhagic & ischemic stroke treatment devices market, by treatment, 2021-2033 (USD Million)
Table 25 Denmark hemorrhagic & ischemic stroke treatment devices market, by end use, 2021-2033 (USD Million)
Table 26 Sweden hemorrhagic & ischemic stroke treatment devices market, by treatment, 2021-2033 (USD Million)
Table 27 Sweden hemorrhagic & ischemic stroke treatment devices market, by end use, 2021-2033 (USD Million)
Table 28 Norway hemorrhagic & ischemic stroke treatment devices market, by treatment, 2021-2033 (USD Million)
Table 29 Norway hemorrhagic & ischemic stroke treatment devices market, by end use, 2021-2033 (USD Million)
Table 30 Asia Pacific hemorrhagic & ischemic stroke treatment devices market, by region, 2021-2033 (USD Million)
Table 31 Asia Pacific hemorrhagic & ischemic stroke treatment devices market, by treatment, 2021-2033 (USD Million)
Table 32 Asia Pacific hemorrhagic & ischemic stroke treatment devices market, by end use, 2021-2033 (USD Million)
Table 33 China hemorrhagic & ischemic stroke treatment devices market, by treatment, 2021-2033 (USD Million)
Table 34 China hemorrhagic & ischemic stroke treatment devices market, by end use, 2021-2033 (USD Million)
Table 35 Japan hemorrhagic & ischemic stroke treatment devices market, by treatment, 2021-2033 (USD Million)
Table 36 Japan hemorrhagic & ischemic stroke treatment devices market, by end use, 2021-2033 (USD Million)
Table 37 India hemorrhagic & ischemic stroke treatment devices market, by treatment, 2021-2033 (USD Million)
Table 38 India hemorrhagic & ischemic stroke treatment devices market, by end use, 2021-2033 (USD Million)
Table 39 South Korea hemorrhagic & ischemic stroke treatment devices market, by treatment, 2021-2033 (USD Million)
Table 40 South Korea hemorrhagic & ischemic stroke treatment devices market, by end use, 2021-2033 (USD Million)
Table 41 Australia hemorrhagic & ischemic stroke treatment devices market, by treatment, 2021-2033 (USD Million)
Table 42 Australia hemorrhagic & ischemic stroke treatment devices market, by end use, 2021-2033 (USD Million)
Table 43 Thailand hemorrhagic & ischemic stroke treatment devices market, by treatment, 2021-2033 (USD Million)
Table 44 Thailand hemorrhagic & ischemic stroke treatment devices market, by treatment, 2021-2033 (USD Million)
Table 45 Latin America hemorrhagic & ischemic stroke treatment devices market, by region, 2021-2033 (USD Million)
Table 46 Latin America hemorrhagic & ischemic stroke treatment devices market, by treatment, 2021-2033 (USD Million)
Table 47 Latin America hemorrhagic & ischemic stroke treatment devices market, by end use, 2021-2033 (USD Million)
Table 48 Brazil hemorrhagic & ischemic stroke treatment devices market, by treatment, 2021-2033 (USD Million)
Table 49 Brazil hemorrhagic & ischemic stroke treatment devices market, by end use, 2021-2033 (USD Million)
Table 50 Argentina hemorrhagic & ischemic stroke treatment devices market, by treatment, 2021-2033 (USD Million)
Table 51 Argentina hemorrhagic & ischemic stroke treatment devices market, by end use, 2021-2033 (USD Million)
Table 52 MEA hemorrhagic & ischemic stroke treatment devices market, by region, 2021-2033 (USD Million)
Table 53 MEA hemorrhagic & ischemic stroke treatment devices market, by treatment, 2021-2033 (USD Million)
Table 54 MEA hemorrhagic & ischemic stroke treatment devices market, by end use, 2021-2033 (USD Million)
Table 55 South Africa hemorrhagic & ischemic stroke treatment devices market, by treatment, 2021-2033 (USD Million)
Table 56 South Africa hemorrhagic & ischemic stroke treatment devices market, by end use, 2021-2033 (USD Million)
Table 57 Saudi Arabia hemorrhagic & ischemic stroke treatment devices market, by treatment, 2021-2033 (USD Million)
Table 58 Saudi Arabia hemorrhagic & ischemic stroke treatment devices market, by end use, 2021-2033 (USD Million)
Table 59 UAE hemorrhagic & ischemic stroke treatment devices market, by treatment, 2021-2033 (USD Million)
Table 60 UAE hemorrhagic & ischemic stroke treatment devices market, by application, 2021-2033 (USD Million)
Table 61 UAE hemorrhagic & ischemic stroke treatment devices market, by end use, 2021-2033 (USD Million)
Table 62 Kuwait hemorrhagic & ischemic stroke treatment devices market, by treatment, 2021-2033 (USD Million)
Table 63 Kuwait hemorrhagic & ischemic stroke treatment devices market, by end use, 2021-2033 (USD Million)
List of Figures
Figure 1 Hemorrhagic & ischemic stroke treatment devices market segmentation
Figure 2 Market research process
Figure 3 Information procurement
Figure 4 Data analysis models
Figure 5 Market formulation and validation
Figure 6 Data validating & publishing
Figure 7 Market snapshot
Figure 8 Segment snapshot
Figure 9 Competitive landscape snapshot
Figure 10 Hemorrhagic & ischemic stroke treatment devices - market size and growth prospects (USD Million)
Figure 11 Hemorrhagic & ischemic stroke treatment devices market: Industry Value Chain Analysis
Figure 12 Hemorrhagic & ischemic stroke treatment devices market: Market Dynamics
Figure 13 Hemorrhagic & ischemic stroke treatment devices market: PORTER’s Analysis
Figure 14 Hemorrhagic & ischemic stroke treatment devices market: PESTEL Analysis
Figure 15 Hemorrhagic & ischemic stroke treatment devices market share by treatment, 2025 & 2033 (USD Million)
Figure 16 Hemorrhagic & ischemic stroke treatment devices market, by treatment: market share, 2023 & 2030
Figure 17 Aneurysm & hemorrhagic stroke interventions market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 18 By indication market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 19 Intracranial aneurysm market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 20 cSDH (MMA Embolization) market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 21 AVM & AVF embolization market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 22 By device market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 23 Embolization coiling systems market share by application, 2025 & 2033 (USD Million)
Figure 24 Bare platinum coils market share by application, 2025 & 2033 (USD Million)
Figure 25 Coated / bioactive coils market share by application, 2025 & 2033 (USD Million)
Figure 26 Flow diversion systems market share by application, 2025 & 2033 (USD Million)
Figure 27 Standard flow-diverting stents (eg, pipeline) market share by application, 2025 & 2033 (USD Million)
Figure 28 Next-generation / surface-modified flow diverters market share by application, 2025 & 2033 (USD Million)
Figure 29 Intrasaccular flow disruption devices market share by application, 2025 & 2033 (USD Million)
Figure 30 Woven endobridge (WEB) market share by application, 2025 & 2033 (USD Million)
Figure 31 Luna aneurysm embolization system market share by application, 2025 & 2033 (USD Million)
Figure 32 Liquid embolization agents market share by application, 2025 & 2033 (USD Million)
Figure 33 Non-adhesive liquid embolics (onyx, squid, PHIL) market share by application, 2025 & 2033 (USD Million)
Figure 34 Adhesive liquid embolics (NBCA) market share by application, 2025 & 2033 (USD Million)
Figure 35 Ischemic stroke interventions (mechanical revascularization) market share by application, 2025 & 2033 (USD Million)
Figure 36 Stent retriever systems market share by application, 2025 & 2033 (USD Million)
Figure 37 Aspiration-based thrombectomy system market share by application, 2025 & 2033 (USD Million)
Figure 38 Cerebral angioplasty & vascular remodeling market share by application, 2025 & 2033 (USD Million)
Figure 39 Balloon angioplasty systems market share by application, 2025 & 2033 (USD Million)
Figure 40 Intracranial & carotid stenting systems market share by application, 2025 & 2033 (USD Million)
Figure 41 Coil-assisted adjunctive devices (balloon-assisted and stent-assisted) market share by application, 2025 & 2033 (USD Million)
Figure 42 Ancillary & procedural access devices market share by application, 2025 & 2033 (USD Million)
Figure 43 Guiding & distal access catheters market share by application, 2025 & 2033 (USD Million)
Figure 44 Microcatheters market share by application, 2025 & 2033 (USD Million)
Figure 45 Access sheaths & wires market share by application, 2025 & 2033 (USD Million)
Figure 46 Hemorrhagic & ischemic stroke treatment devices market share by end use, 2025 & 2033 (USD Million)
Figure 47 Hemorrhagic & ischemic stroke treatment devices market, by end use: market share, 2023 & 2030
Figure 48 Hospitals market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 49 Specialty neurosurgery centers market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 50 Ambulatory surgical centers market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 51 Regional marketplace: key takeaways
Figure 52 North America hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 53 US hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 54 Canada hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 55 Mexico hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 56 Europe hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 57 UK hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 58 Germany hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 59 France hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 60 Italy hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 61 Spain hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 62 Sweden hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 63 Denmark hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 64 Norway hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 65 Asia Pacific hemorrhagic & ischemic stroke treatment devices market estimates and forecast, 2021-2033 (USD Million)
Figure 66 China hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 67 Japan hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 68 India hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 69 South Korea hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 70 Australia hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 71 Thailand hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 72 Latin America hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 73 Brazil hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 74 Argentina hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 75 MEA hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 76 South Africa hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 77 Saudi Arabia hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 78 UAE hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 79 Kuwait hemorrhagic & ischemic stroke treatment devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 80 Key company categorization
Figure 81 Company market positioning
Figure 82 Key company market share analysis, 2025
Figure 83 Strategic framework
